ReviewFrontiers in public health2025
From infectious diseases to chronic diseases: the paradigm shift of spatial epidemiology in disease prevention and control.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- EpiGIS pro: an AI-powered geospatial intelligence platform for integrated disease surveillance and predictive analytics.International journal of health geographics · 2026Article
- The Relationship Between Urban Characteristics and Non-Communicable Diseases-Conceptual Framework of the HORUS Project.International journal of environmental research and public health · 2026Article
- Global Spatiotemporal Dynamics of African Swine Fever: An Integrated Multi-Scale Spatial and Time-Series Analysis.Viruses · 2026Article
- Spatiotemporal heterogeneity and socioeconomic determinants of syphilis incidence in Xining, Northwest China: a geospatial analysis.BMC infectious diseases · 2026Article
- Spatial Epidemiological Approach to Tuberculosis Treatment Outcomes in a Tertiary-Level Hospital: A Retrospective Analysis.Tropical medicine and infectious disease · 2026Article
- Vaccines for microbial eye diseases in the era of data science: opportunities and challenges.Frontiers in immunology · 2026Review
- Characterization of Gastrointestinal Parasites in Grazing Sheep in Mountain, Piedmont, and Savanna Conditions of Casanare, Colombia.Veterinary medicine international · 2026Article
- Reconstructing severe acute respiratory infection dynamics from ICD-10 hospital discharge data: a 10-year analysis of 11.2 million discharges in Ecuador, 2014-2023.Frontiers in public health · 2026Article
- Spatiotemporal Analysis of Mortality from Cardiomyopathies in Brazil between 2001 and 2021.Arquivos brasileiros de cardiologia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spatial epidemiology, as an important branch of epidemiology, has undergone a significant paradigm shift from infectious disease prevention and control to chronic disease management. This paper systematically reviews the application progress of spatial epidemiology in the study of infectious diseases (e.g., malaria, HIV) and chronic diseases (e.g., cancer, cardiovascular diseases), focusing on its role in identifying spatial distribution patterns of diseases, assessing environmental exposures, and supporting health decision-making. The paper compares the differences in data characteristics, analytical methods, and modeling strategies between infectious and chronic diseases, and discusses the impact of multi-scale analysis, data aggregation, and the Modifiable Areal Unit Problem on research results. Furthermore, this paper reviews the innovative value of Geographic Information Systems, remote sensing technology, mobile positioning, and multi-source data fusion in promoting precision public health practices. Finally, the article points out the current challenges faced by spatial epidemiology in privacy ethics, causal inference, and model robustness, and prospects future directions such as AI-enabled multi-omics integration and spatial decision support systems under global health governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.